Logo for Allogene Therapeutics Inc

Allogene Therapeutics Investor Relations Material

Latest events

Logo for Allogene Therapeutics Inc

Q1 2025

Allogene Therapeutics
Logo for Allogene Therapeutics

Q1 2025

13 May, 2025
Logo for Allogene Therapeutics

Corporate Presentation

12 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Allogene Therapeutics Inc

Access all reports
Allogene Therapeutics Inc is a biotechnology company focused on developing allogeneic CAR T cell therapies for cancer treatment. The company’s approach uses gene-editing and cell engineering technologies to produce off-the-shelf immunotherapies designed to target various hematologic and solid tumors. Its operations span research, clinical trials, and manufacturing. Allogene Therapeutics Inc is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.